Mezzanine and Shareholders' Equity (Tables)

12 Months Ended

Dec. 31, 2018

Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions

The stock options under the Exclusivity Amendment Agreement were accounted for at fair value, as determined using the Black-Scholes option pricing model and the following assumptions:

Year ended December 31,	2018		2017
Expected term	0.75 years		0.93 - 1.75 years
Expected volatility	38.10% - 41.60	%	38.10% - 41.60	%
Risk-free interest rate	1.64% - 1.86	%	1.64% - 1.86	%
Market value of common stock	$0.52 - $0.76		$0.52 - $0.76
Annual dividend yield	2.23% - 3.53	%	2.23% - 3.53	%
Forfeiture rate	0% - 6.8	%	0% - 6.8	%

Summary of Share-Based Compensation Expense of Stock Option Awards Granted

Share-based compensation expense related to option awards granted to primary care physicians with Exclusivity Agreements to purchase shares of APC’s common stock, are recognized over their respective vesting periods, and consisted of the following:

Year ended December 31,	2018		2017
Share-based compensation expense:
General and administrative		809,528		2,113,116
	$	809,528	$	2,113,116

Warrants Outstanding

The Company’s outstanding warrants consisted of the following:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
								(In Millions)
Warrants outstanding at January 1, 2017		-		$	-		-	$	-
Warrants assumed in the Merger		1,898,541		$	9.06		2.69	$	1.8
Warrants granted (see Note 3)		1,750,000			10.49		5.00		-
Warrants outstanding at December 31, 2017		3,648,541		$	9.75		3.74	$	52.0
Warrants granted		-			-		-		-
Warrants exercised		(286,357	)		7.84		-		3.0
Warrants forfeited		(30,189	)		4.50		-		-
Warrants outstanding at December 31, 2018		3,331,995		$	9.93		2.97	$	33.1

								Weighted
				Weighted				Average
				Average				Exercise Price
Exercise Price Per		Warrants		Remaining		Warrants		Per
Share		Outstanding		Contractual Life		Exercisable		Share
$	9.00		1,079,622		1.79		1,079,622	$	9.00
	10.00		1,421,508		3.29		1,421,508		10.00
	11.00		830,865		3.94		830,865		11.00
$	9.00 –10.00		3,331,995		2.97		3,331,995	$	9.92

Exclusivity Amendment Agreement, APC [Member]

Stock Option Transactions Under Stock Option Plans

Outstanding stock options granted to primary care physicians to purchase shares of APC’s common stock consisted of the following:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value
Options outstanding at January 1, 2017		1,910,400		$	0.167		2.75	$	1,138,598
Options granted		-			-		-		-
Options exercised		(1,056,600	)		0.167		-		(629,734	)
Options forfeited		-			-		-		-
Options outstanding at December 31, 2017		853,800		$	0.167		1.75	$	508,864
Options granted		-			-		-		-
Options exercised		-			-		-		-
Options forfeited		-			-		-		-
Options outstanding at December 31, 2018		853,800		$	0.167		0.75	$	508,864
Options exercisable at December 31, 2018		853,800		$	0.167		0.75	$	508,864

Employee Stock Option [Member]

Stock Option Transactions Under Stock Option Plans

The Company’s outstanding stock options consisted of the following:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (Years)		Aggregate Intrinsic Value (in millions)
Options outstanding at January 1, 2017		-		$	-		-	$	-
Options assumed in the Merger (see Note 3)		1,141,040			3.95		5.85		22.6
Options granted		-			-		-		-
Options exercised		-			-		-		-
Options forfeited		-			-		-		-
Options outstanding at December 31, 2017		1,141,040		$	3.95		5.79	$	22.6
Options granted		155,000			9.85		-		-
Options exercised		(639,800	)		4.11		-		9.8
Options forfeited		(9,000	)		3.41		-		-
Options outstanding at December 31, 2018		647,240		$	5.62		4.13	$	9.2
Options exercisable at December 31, 2018		647,240		$	5.62		4.13	$	9.2